Home > > > > Report Detail

Global Encephalitis Vaccination Market Growth 2023-2029

Publisher Name :
Date: 04-Jan-2023
No. of pages: 95

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus.

LPI (LP Information)' newest research report, the "Encephalitis Vaccination Industry Forecast" looks at past sales and reviews total world Encephalitis Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Encephalitis Vaccination sales for 2023 through 2029. With Encephalitis Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encephalitis Vaccination industry.

This Insight Report provides a comprehensive analysis of the global Encephalitis Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Encephalitis Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Encephalitis Vaccination market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encephalitis Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encephalitis Vaccination.

The global Encephalitis Vaccination market size is projected to grow from US$ 1263.1 million in 2022 to US$ 1875.5 million in 2029; it is expected to grow at a CAGR of 1875.5 from 2023 to 2029.

The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Encephalitis Vaccination market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Encephalitis B Vaccine

- Encephalitis Attenuated Live Vaccine

Segmentation by application

- Public Hospital

- Private Hospital

- Clinic

- Other

The below companies that are profiled

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Novartis

- Sanofi

- Chengdu Institute of Biological Products

- Wuhan Institute of Biological Products

- Lanzhou Institute of Biological Products

- Beijing Taitan

- Valneva

- Bharat Biotech

- Liaoning Chengda

Key Questions Addressed in this Report

What is the 10-year outlook for the global Encephalitis Vaccination market?

What factors are driving Encephalitis Vaccination market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Encephalitis Vaccination market opportunities vary by end market size?

How does Encephalitis Vaccination break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Encephalitis Vaccination Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Encephalitis Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Encephalitis Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Encephalitis Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Encephalitis Vaccination Segment by Type
2.2.1 Encephalitis B Vaccine
2.2.2 Encephalitis Attenuated Live Vaccine
2.3 Encephalitis Vaccination Sales by Type
2.3.1 Global Encephalitis Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Encephalitis Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Encephalitis Vaccination Sale Price by Type (2018-2023)
2.4 Encephalitis Vaccination Segment by Application
2.4.1 Public Hospital
2.4.2 Private Hospital
2.4.3 Clinic
2.4.4 Other
2.5 Encephalitis Vaccination Sales by Application
2.5.1 Global Encephalitis Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Encephalitis Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Encephalitis Vaccination Sale Price by Application (2018-2023)
3 Global Encephalitis Vaccination by Company
3.1 Global Encephalitis Vaccination Breakdown Data by Company
3.1.1 Global Encephalitis Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Encephalitis Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Encephalitis Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Encephalitis Vaccination Revenue by Company (2018-2023)
3.2.2 Global Encephalitis Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Encephalitis Vaccination Sale Price by Company
3.4 Key Manufacturers Encephalitis Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Encephalitis Vaccination Product Location Distribution
3.4.2 Players Encephalitis Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Encephalitis Vaccination by Geographic Region
4.1 World Historic Encephalitis Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Encephalitis Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Encephalitis Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Encephalitis Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Encephalitis Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Encephalitis Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Encephalitis Vaccination Sales Growth
4.4 APAC Encephalitis Vaccination Sales Growth
4.5 Europe Encephalitis Vaccination Sales Growth
4.6 Middle East & Africa Encephalitis Vaccination Sales Growth
5 Americas
5.1 Americas Encephalitis Vaccination Sales by Country
5.1.1 Americas Encephalitis Vaccination Sales by Country (2018-2023)
5.1.2 Americas Encephalitis Vaccination Revenue by Country (2018-2023)
5.2 Americas Encephalitis Vaccination Sales by Type
5.3 Americas Encephalitis Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Encephalitis Vaccination Sales by Region
6.1.1 APAC Encephalitis Vaccination Sales by Region (2018-2023)
6.1.2 APAC Encephalitis Vaccination Revenue by Region (2018-2023)
6.2 APAC Encephalitis Vaccination Sales by Type
6.3 APAC Encephalitis Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Encephalitis Vaccination by Country
7.1.1 Europe Encephalitis Vaccination Sales by Country (2018-2023)
7.1.2 Europe Encephalitis Vaccination Revenue by Country (2018-2023)
7.2 Europe Encephalitis Vaccination Sales by Type
7.3 Europe Encephalitis Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Encephalitis Vaccination by Country
8.1.1 Middle East & Africa Encephalitis Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Encephalitis Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Encephalitis Vaccination Sales by Type
8.3 Middle East & Africa Encephalitis Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Encephalitis Vaccination
10.3 Manufacturing Process Analysis of Encephalitis Vaccination
10.4 Industry Chain Structure of Encephalitis Vaccination
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Encephalitis Vaccination Distributors
11.3 Encephalitis Vaccination Customer
12 World Forecast Review for Encephalitis Vaccination by Geographic Region
12.1 Global Encephalitis Vaccination Market Size Forecast by Region
12.1.1 Global Encephalitis Vaccination Forecast by Region (2024-2029)
12.1.2 Global Encephalitis Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Encephalitis Vaccination Forecast by Type
12.7 Global Encephalitis Vaccination Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Encephalitis Vaccination Product Portfolios and Specifications
13.1.3 Novartis Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Encephalitis Vaccination Product Portfolios and Specifications
13.2.3 Sanofi Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Chengdu Institute of Biological Products
13.3.1 Chengdu Institute of Biological Products Company Information
13.3.2 Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Chengdu Institute of Biological Products Main Business Overview
13.3.5 Chengdu Institute of Biological Products Latest Developments
13.4 Wuhan Institute of Biological Products
13.4.1 Wuhan Institute of Biological Products Company Information
13.4.2 Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Wuhan Institute of Biological Products Main Business Overview
13.4.5 Wuhan Institute of Biological Products Latest Developments
13.5 Lanzhou Institute of Biological Products
13.5.1 Lanzhou Institute of Biological Products Company Information
13.5.2 Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Lanzhou Institute of Biological Products Main Business Overview
13.5.5 Lanzhou Institute of Biological Products Latest Developments
13.6 Beijing Taitan
13.6.1 Beijing Taitan Company Information
13.6.2 Beijing Taitan Encephalitis Vaccination Product Portfolios and Specifications
13.6.3 Beijing Taitan Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Beijing Taitan Main Business Overview
13.6.5 Beijing Taitan Latest Developments
13.7 Valneva
13.7.1 Valneva Company Information
13.7.2 Valneva Encephalitis Vaccination Product Portfolios and Specifications
13.7.3 Valneva Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Valneva Main Business Overview
13.7.5 Valneva Latest Developments
13.8 Bharat Biotech
13.8.1 Bharat Biotech Company Information
13.8.2 Bharat Biotech Encephalitis Vaccination Product Portfolios and Specifications
13.8.3 Bharat Biotech Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bharat Biotech Main Business Overview
13.8.5 Bharat Biotech Latest Developments
13.9 Liaoning Chengda
13.9.1 Liaoning Chengda Company Information
13.9.2 Liaoning Chengda Encephalitis Vaccination Product Portfolios and Specifications
13.9.3 Liaoning Chengda Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Liaoning Chengda Main Business Overview
13.9.5 Liaoning Chengda Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Encephalitis Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Encephalitis Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Encephalitis B Vaccine
Table 4. Major Players of Encephalitis Attenuated Live Vaccine
Table 5. Global Encephalitis Vaccination Sales by Type (2018-2023) & (K Units)
Table 6. Global Encephalitis Vaccination Sales Market Share by Type (2018-2023)
Table 7. Global Encephalitis Vaccination Revenue by Type (2018-2023) & ($ million)
Table 8. Global Encephalitis Vaccination Revenue Market Share by Type (2018-2023)
Table 9. Global Encephalitis Vaccination Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Encephalitis Vaccination Sales by Application (2018-2023) & (K Units)
Table 11. Global Encephalitis Vaccination Sales Market Share by Application (2018-2023)
Table 12. Global Encephalitis Vaccination Revenue by Application (2018-2023)
Table 13. Global Encephalitis Vaccination Revenue Market Share by Application (2018-2023)
Table 14. Global Encephalitis Vaccination Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Encephalitis Vaccination Sales by Company (2018-2023) & (K Units)
Table 16. Global Encephalitis Vaccination Sales Market Share by Company (2018-2023)
Table 17. Global Encephalitis Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Encephalitis Vaccination Revenue Market Share by Company (2018-2023)
Table 19. Global Encephalitis Vaccination Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Encephalitis Vaccination Producing Area Distribution and Sales Area
Table 21. Players Encephalitis Vaccination Products Offered
Table 22. Encephalitis Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Encephalitis Vaccination Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Encephalitis Vaccination Sales Market Share Geographic Region (2018-2023)
Table 27. Global Encephalitis Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Encephalitis Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Encephalitis Vaccination Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Encephalitis Vaccination Sales Market Share by Country/Region (2018-2023)
Table 31. Global Encephalitis Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Encephalitis Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Encephalitis Vaccination Sales by Country (2018-2023) & (K Units)
Table 34. Americas Encephalitis Vaccination Sales Market Share by Country (2018-2023)
Table 35. Americas Encephalitis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Encephalitis Vaccination Revenue Market Share by Country (2018-2023)
Table 37. Americas Encephalitis Vaccination Sales by Type (2018-2023) & (K Units)
Table 38. Americas Encephalitis Vaccination Sales by Application (2018-2023) & (K Units)
Table 39. APAC Encephalitis Vaccination Sales by Region (2018-2023) & (K Units)
Table 40. APAC Encephalitis Vaccination Sales Market Share by Region (2018-2023)
Table 41. APAC Encephalitis Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Encephalitis Vaccination Revenue Market Share by Region (2018-2023)
Table 43. APAC Encephalitis Vaccination Sales by Type (2018-2023) & (K Units)
Table 44. APAC Encephalitis Vaccination Sales by Application (2018-2023) & (K Units)
Table 45. Europe Encephalitis Vaccination Sales by Country (2018-2023) & (K Units)
Table 46. Europe Encephalitis Vaccination Sales Market Share by Country (2018-2023)
Table 47. Europe Encephalitis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Encephalitis Vaccination Revenue Market Share by Country (2018-2023)
Table 49. Europe Encephalitis Vaccination Sales by Type (2018-2023) & (K Units)
Table 50. Europe Encephalitis Vaccination Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Encephalitis Vaccination Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Encephalitis Vaccination Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Encephalitis Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Encephalitis Vaccination Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Encephalitis Vaccination Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Encephalitis Vaccination Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Encephalitis Vaccination
Table 58. Key Market Challenges & Risks of Encephalitis Vaccination
Table 59. Key Industry Trends of Encephalitis Vaccination
Table 60. Encephalitis Vaccination Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Encephalitis Vaccination Distributors List
Table 63. Encephalitis Vaccination Customer List
Table 64. Global Encephalitis Vaccination Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Encephalitis Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Encephalitis Vaccination Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Encephalitis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Encephalitis Vaccination Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Encephalitis Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Encephalitis Vaccination Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Encephalitis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Encephalitis Vaccination Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Encephalitis Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Encephalitis Vaccination Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Encephalitis Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Encephalitis Vaccination Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Encephalitis Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis Encephalitis Vaccination Product Portfolios and Specifications
Table 80. Novartis Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Novartis Main Business
Table 82. Novartis Latest Developments
Table 83. Sanofi Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Encephalitis Vaccination Product Portfolios and Specifications
Table 85. Sanofi Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Sanofi Main Business
Table 87. Sanofi Latest Developments
Table 88. Chengdu Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 89. Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 90. Chengdu Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Chengdu Institute of Biological Products Main Business
Table 92. Chengdu Institute of Biological Products Latest Developments
Table 93. Wuhan Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 94. Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 95. Wuhan Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. Wuhan Institute of Biological Products Main Business
Table 97. Wuhan Institute of Biological Products Latest Developments
Table 98. Lanzhou Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 99. Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 100. Lanzhou Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Lanzhou Institute of Biological Products Main Business
Table 102. Lanzhou Institute of Biological Products Latest Developments
Table 103. Beijing Taitan Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 104. Beijing Taitan Encephalitis Vaccination Product Portfolios and Specifications
Table 105. Beijing Taitan Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Beijing Taitan Main Business
Table 107. Beijing Taitan Latest Developments
Table 108. Valneva Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 109. Valneva Encephalitis Vaccination Product Portfolios and Specifications
Table 110. Valneva Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Valneva Main Business
Table 112. Valneva Latest Developments
Table 113. Bharat Biotech Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 114. Bharat Biotech Encephalitis Vaccination Product Portfolios and Specifications
Table 115. Bharat Biotech Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Bharat Biotech Main Business
Table 117. Bharat Biotech Latest Developments
Table 118. Liaoning Chengda Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 119. Liaoning Chengda Encephalitis Vaccination Product Portfolios and Specifications
Table 120. Liaoning Chengda Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Liaoning Chengda Main Business
Table 122. Liaoning Chengda Latest Developments
List of Figures
Figure 1. Picture of Encephalitis Vaccination
Figure 2. Encephalitis Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Encephalitis Vaccination Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Encephalitis Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Encephalitis Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Encephalitis B Vaccine
Figure 10. Product Picture of Encephalitis Attenuated Live Vaccine
Figure 11. Global Encephalitis Vaccination Sales Market Share by Type in 2022
Figure 12. Global Encephalitis Vaccination Revenue Market Share by Type (2018-2023)
Figure 13. Encephalitis Vaccination Consumed in Public Hospital
Figure 14. Global Encephalitis Vaccination Market: Public Hospital (2018-2023) & (K Units)
Figure 15. Encephalitis Vaccination Consumed in Private Hospital
Figure 16. Global Encephalitis Vaccination Market: Private Hospital (2018-2023) & (K Units)
Figure 17. Encephalitis Vaccination Consumed in Clinic
Figure 18. Global Encephalitis Vaccination Market: Clinic (2018-2023) & (K Units)
Figure 19. Encephalitis Vaccination Consumed in Other
Figure 20. Global Encephalitis Vaccination Market: Other (2018-2023) & (K Units)
Figure 21. Global Encephalitis Vaccination Sales Market Share by Application (2022)
Figure 22. Global Encephalitis Vaccination Revenue Market Share by Application in 2022
Figure 23. Encephalitis Vaccination Sales Market by Company in 2022 (K Units)
Figure 24. Global Encephalitis Vaccination Sales Market Share by Company in 2022
Figure 25. Encephalitis Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Encephalitis Vaccination Revenue Market Share by Company in 2022
Figure 27. Global Encephalitis Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Encephalitis Vaccination Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Encephalitis Vaccination Sales 2018-2023 (K Units)
Figure 30. Americas Encephalitis Vaccination Revenue 2018-2023 ($ Millions)
Figure 31. APAC Encephalitis Vaccination Sales 2018-2023 (K Units)
Figure 32. APAC Encephalitis Vaccination Revenue 2018-2023 ($ Millions)
Figure 33. Europe Encephalitis Vaccination Sales 2018-2023 (K Units)
Figure 34. Europe Encephalitis Vaccination Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Encephalitis Vaccination Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Encephalitis Vaccination Revenue 2018-2023 ($ Millions)
Figure 37. Americas Encephalitis Vaccination Sales Market Share by Country in 2022
Figure 38. Americas Encephalitis Vaccination Revenue Market Share by Country in 2022
Figure 39. Americas Encephalitis Vaccination Sales Market Share by Type (2018-2023)
Figure 40. Americas Encephalitis Vaccination Sales Market Share by Application (2018-2023)
Figure 41. United States Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Encephalitis Vaccination Sales Market Share by Region in 2022
Figure 46. APAC Encephalitis Vaccination Revenue Market Share by Regions in 2022
Figure 47. APAC Encephalitis Vaccination Sales Market Share by Type (2018-2023)
Figure 48. APAC Encephalitis Vaccination Sales Market Share by Application (2018-2023)
Figure 49. China Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Encephalitis Vaccination Sales Market Share by Country in 2022
Figure 57. Europe Encephalitis Vaccination Revenue Market Share by Country in 2022
Figure 58. Europe Encephalitis Vaccination Sales Market Share by Type (2018-2023)
Figure 59. Europe Encephalitis Vaccination Sales Market Share by Application (2018-2023)
Figure 60. Germany Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Encephalitis Vaccination Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Encephalitis Vaccination Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Encephalitis Vaccination Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Encephalitis Vaccination Sales Market Share by Application (2018-2023)
Figure 69. Egypt Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Encephalitis Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Encephalitis Vaccination in 2022
Figure 75. Manufacturing Process Analysis of Encephalitis Vaccination
Figure 76. Industry Chain Structure of Encephalitis Vaccination
Figure 77. Channels of Distribution
Figure 78. Global Encephalitis Vaccination Sales Market Forecast by Region (2024-2029)
Figure 79. Global Encephalitis Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Encephalitis Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Encephalitis Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Encephalitis Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Encephalitis Vaccination Revenue Market Share Forecast by Application (2024-2029)
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs